447 related articles for article (PubMed ID: 16877988)
1. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.
Hartley JL; Brown RM; Tybulewicz A; Hayes P; Wilson DC; Gillett P; McKiernan P
J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988
[TBL] [Abstract][Full Text] [Related]
2. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
[TBL] [Abstract][Full Text] [Related]
3. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
[TBL] [Abstract][Full Text] [Related]
5. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
[TBL] [Abstract][Full Text] [Related]
6. Serum hyaluronic acid as a marker of hepatic fibrosis.
Khan JA; Khan FA; Dilawar M; Ijaz A; Khan NA; Mehmood T
J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578
[TBL] [Abstract][Full Text] [Related]
7. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.
Kelleher TB; Mehta SH; Bhaskar R; Sulkowski M; Astemborski J; Thomas DL; Moore RE; Afdhal NH
J Hepatol; 2005 Jul; 43(1):78-84. PubMed ID: 15894397
[TBL] [Abstract][Full Text] [Related]
8. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH
Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease.
Suzuki A; Angulo P; Lymp J; Li D; Satomura S; Lindor K
Liver Int; 2005 Aug; 25(4):779-86. PubMed ID: 15998429
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease.
Testa E; Malfatti F; Milazzo S; Cordiviola C; Cotellessa T; Marabotto E; Giannini E; Ceppa P; Mamone M; Risso D; Testa R
Liver Int; 2006 May; 26(4):439-44. PubMed ID: 16629647
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease.
Nobili V; Alisi A; Torre G; De Vito R; Pietrobattista A; Morino G; De Ville De Goyet J; Bedogni G; Pinzani M
Transl Res; 2010 Oct; 156(4):229-34. PubMed ID: 20875899
[TBL] [Abstract][Full Text] [Related]
13. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.
Corpechot C; Poujol-Robert A; Wendum D; Galotte M; Chrétien Y; Poupon RE; Poupon R
Liver Int; 2004 Jun; 24(3):187-93. PubMed ID: 15189267
[TBL] [Abstract][Full Text] [Related]
14. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
[TBL] [Abstract][Full Text] [Related]
15. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.
Lebensztejn DM; Wierzbicka A; Socha P; Pronicki M; Skiba E; Werpachowska I; Kaczmarski M
Acta Biochim Pol; 2011; 58(4):563-6. PubMed ID: 22140659
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
Parise ER; Oliveira AC; Figueiredo-Mendes C; Lanzoni V; Martins J; Nader H; Ferraz ML
Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease.
Kaneda H; Hashimoto E; Yatsuji S; Tokushige K; Shiratori K
J Gastroenterol Hepatol; 2006 Sep; 21(9):1459-65. PubMed ID: 16911693
[TBL] [Abstract][Full Text] [Related]
19. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
Xie SB; Yao JL; Zheng SS; Yao CL; Zheng RQ
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic value of five serum markers for liver fibrosis].
Luo R; Yang S; Xie J; Zhao Z; He Y; Yao J
Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]